We are Neotherix
Neotherix’ innovative technology utilises the body’s ability to repair itself. Our advances in soft tissue repair provide a patient’s own cells with the 3D architecture they need to heal a wound. Using bioresorbable, regenerative scaffolds and electrospinning, our solutions deliver advanced repair for problem wounds, including the potential to reduce the need for antibiotics when treating infected sites, as well as delivering significant healthcare cost savings.
More about usIn our experience [EktoTherix] is easy to use in practice and is not painful for the patient on application or during the healing process. From the study we have done it does appear to accelerate granulation.
Dr Rob Ellis
Consultant Dermatologist, NHS South Tees
It [EktoTherix] has promoted very rapid granulation in some of the cases and rapid epithelialisation, faster than one would have expected with dressings alone … it would appear to be very promising indeed.
Dr Calum Lyon
Consultant Dermatologist, NHS York
Collaborators & Funders
Neotherix Strengthens Product Development Team
We are delighted to welcome our new Production Technologist, Daisy Redman.
Daisy will play a key role in the project management of device manufacture and development programmes.
Read moreClare Lankester joins as Technology Programme Manager
Welcome to Dr Clare Lankester as Technology Programme Manager. Clare will have oversight of the Neotherix product portfolio with a view to moving these through appropriate Technology Readiness Levels to commercialisation.
Read moreGet in touch with us
We’re always happy to hear from potential investors and funding partners as well as researchers, universities and networks interested in our products and development work.